NCT06101004View on ClinicalTrials.gov

A Multi-center, Non-interventional Prospective Clinical Trial to Evaluate the Safety and Effectiveness of CVA-FLOW

Not yet recruitingOBSERVATIONAL
Enrollment

460

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
Stroke
Interventions
DEVICE

CVA-Flow

CVA-FLOW Software Device is indicated for the detection of Stroke and LVO in patients with suspected stroke.

Trial Locations (2)

10029

Icahn School of Medicine at Mount Sinai, New York

08035

Hospital Vall d'Hebron - Neurology, Barcelona

Sponsors

Lead Sponsor

Cvaid Medical
All Listed Sponsors
collaborator

Donawa Lifescience Consulting

UNKNOWN

lead

Cvaid Medical

INDUSTRY

NCT06101004 - A Multi-center, Non-interventional Prospective Clinical Trial to Evaluate the Safety and Effectiveness of CVA-FLOW | Biotech Hunter | Biotech Hunter